Alaunos Therapeutics Inc.

NASDAQ: TCRT · Real-Time Price · USD
1.82
-0.07 (-3.70%)
At close: Aug 22, 2025, 3:59 PM
1.68
-7.69%
After-hours: Aug 22, 2025, 07:57 PM EDT

Alaunos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-4.68M -35.14M -37.73M -78.75M
Depreciation & Amortization
2K 2.31M 2.76M 2.6M
Stock-Based Compensation
435K 2.8M 3.53M 10.77M
Other Working Capital
n/a -5.48M -2.14M 2.52M
Other Non-Cash Items
-729K 6.14M 3.27M 383K
Deferred Income Tax
n/a n/a n/a 740K
Change in Working Capital
-729K -6.25M -1.06M 2.79M
Operating Cash Flow
-4.97M -30.14M -29.23M -61.47M
Capital Expenditures
n/a -197K -216K -3.32M
Cash Acquisitions
n/a n/a 23K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 1.54M 23K n/a
Investing Cash Flow
n/a 1.35M -193K -3.32M
Debt Repayment
n/a -18.11M -8.33M 25M
Common Stock Repurchased
n/a n/a -45K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -125K 21K 776K
Financial Cash Flow
n/a -18.14M 6.37M 25.78M
Net Cash Flow
-4.97M -46.93M -23.06M -39.02M
Free Cash Flow
-4.97M -30.34M -29.45M -64.79M